Spatial Genomics & Transcriptomics Market

The spatial genomics & transcriptomics market is projected to reach USD 1.23 billion by 2031 from USD 0.67 billion in 2026, registering a CAGR of 12.9% during the forecast period. The market is driven by the increasing adoption of spatial genomics and transcriptomics in drug discovery and development and the introduction of novel spatial analysis products. These technologies enable researchers to characterize gene expression while preserving tissue architecture, supporting biomarker identification, disease research, and precision medicine.

10x Genomics (US), Bruker (US), Illumina, Inc. (US), Bio- Techne (US), and Standard BioTools Inc. (US) are the key players in the spatial genomics & transcriptomics market. These market players have adopted various approaches, including product and service launches, collaborations, acquisitions, agreements, and expansions, to enhance their market positions. For instance, in June 2026, Illumina launched the StrataMap Spatial Solution, a sequencing-based spatial whole-transcriptome research platform that provides single-cell resolution. This solution enables unbiased spatial transcriptomics profiling across tissues, supporting discovery research and expanding Illumina’s presence in the spatial genomics & transcriptomics market.

To know about the assumptions considered for the study download the pdf brochure

10x Genomics (US)

10x Genomics is a key player in spatial genomics and transcriptomics, offering the Visium and Xenium platforms for spatial gene expression analysis. Visium enables genome-wide spatial transcriptomics, while Xenium supports high-resolution in situ analysis of RNA targets within intact tissue samples. Its portfolio includes instruments, tissue-processing reagents, assay kits, and consumables that support spatial profiling workflows. These technologies are widely applied in cancer research, neuroscience, immunology, and developmental biology. By combining spatially resolved molecular data with advanced visualization and analysis tools, the company supports researchers in investigating tissue architecture, cellular interactions, and disease mechanisms.

Illumina, Inc. (US)

Illumina plays a major role in the spatial genomics & transcriptomics market through its sequencing platforms, library preparation kits, sequencing reagents, and data analysis solutions. The company’s sequencing technologies support spatial workflows by enabling high-throughput analysis of genetic material and downstream molecular profiling. Its sequencing ecosystem supports applications in oncology, biomarker discovery, gene expression research, and precision medicine. Its platforms and consumables also complement spatial transcriptomics workflows that combine tissue-based molecular information with sequencing-based analysis, supporting scalable research across academic and pharmaceutical settings.

Market Ranking

The spatial genomics & transcriptomics market comprises established life sciences and molecular analysis companies alongside specialized spatial biology technology providers. Key players include Illumina, Inc. (US), 10x Genomics (US), and Bruker (US). Illumina supports spatial workflows through sequencing platforms, reagents, and data analysis solutions that enable downstream molecular profiling. 10x Genomics strengthens its position through the Visium and Xenium platforms, which support spatial gene expression analysis at different resolutions. Bruker contributes through its CosMx Spatial Molecular Imager technology, including consumables as well as software. Collectively, these companies support applications in oncology, neuroscience, immunology, biomarker discovery, and precision medicine. Their product portfolios address key research requirements, including high-resolution gene expression analysis, preservation of tissue architecture, and characterization of cellular interactions. Continued product innovation, expansion of spatial analysis capabilities, and integration with sequencing and bioinformatics workflows are expected to support wider adoption across pharmaceutical and biotechnology companies, academic and research institutes, and clinical research settings.

Related Reports:

Spatial Genomics & Transcriptomics Market by Product (Instrument, Consumable, Service), Technique (Transcriptomics [IHC, ISH, RNA Sequencing], Genomics [LCM]), Service Type (Sample Prep, Analytical), Application (Drug Discovery) - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]